Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Irinotecan × Other neoplasm × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 31 Thoracic 2 CNS 2 Sarcoma 1 Other solid neoplasm 1 Other neoplasm 1

Conditions

Advanced Malignant Neoplasm 1

Interventions

venetoclax 1 toripalimab 1 fludarabine 1 Irinotecan 1 Influenza Vaccines 1 Docetaxel 1 Decitabine 1 Control Groups 1 Carboplatin 1 Capacity Building 1 Busulfan 1 Blood Specimen Collection 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06394713 2024-05-01

A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡